Centenial Surgical Suture Ltd vs Lotus Eye Hospital Institute Ltd Stock Comparison
Centenial Surgical Suture Ltd vs Lotus Eye Hospital Institute Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Centenial Surgical Suture Ltd is ₹ 67.95 as of 23 Oct 15:30
. The P/E Ratio of Centenial Surgical Suture Ltd changed from 24.1 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Lotus Eye Hospital & Institute Ltd changed from 55.9 on March 2021 to 2533 on March 2026 . This represents a CAGR of 88.83% over 6 years The Market Cap of Centenial Surgical Suture Ltd changed from ₹ 15.6 crore on March 2021 to ₹ 27.83 crore on March 2026 . This represents a CAGR of 10.13% over 6 yearsThe Market Cap of Lotus Eye Hospital & Institute Ltd changed from ₹ 87.14 crore on March 2021 to ₹ 210.77 crore on March 2026 . This represents a CAGR of 15.86% over 6 years The revenue of Centenial Surgical Suture Ltd for the Jun '26 is ₹ 15.35 crore as compare to the Mar '26 revenue of ₹ 12.65 crore. This represent the growth of 21.34% The revenue of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 17.27 crore as compare to the Mar '26 revenue of ₹ 14.09 crore. This represent the growth of 22.57% The ebitda of Centenial Surgical Suture Ltd for the Jun '26 is ₹ 2.19 crore as compare to the Mar '26 ebitda of ₹ 1 crore. This represent the growth of 119% The ebitda of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 3.15 crore as compare to the Mar '26 ebitda of ₹ 0.95 crore. This represent the growth of 231.58% The net profit of Centenial Surgical Suture Ltd changed from ₹ 0.3 crore to ₹ 0.74 crore over 9 quarters. This represents a CAGR of 49.37%
The net profit of Lotus Eye Hospital & Institute Ltd changed from ₹ 0.62 crore to ₹ 0.61 crore over 9 quarters. This represents a CAGR of -0.72%
The Dividend Payout of Centenial Surgical Suture Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Lotus Eye Hospital & Institute Ltd changed from 66.24 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 years .
About Centenial Surgical Suture Ltd
Incorporated in 1995, Centenial Surgical Suture Limited is engaged in the manufacture and sale of surgical sutures in India.
The company offers absorbable sutures that include natural and synthetic sutures and non absorbable sutures comprising needles for cardiovascular surgery, monofilament polyamide atraumatic needle suture combinations, monofilament stainless steel, and temporary pacemaker electrodes.
It also provides female urinary incontinency sets, titanium haemostatic clips for cardiovascular surgery, non absorbable.
Company leverages the expertise and application knowledge of the global suture requirements for cardiovascular sutures in particular, to bring advanced atraumatic needle product development to the Indian Surgeons.
Continuous innovation in the areas of design, research and development of atraumatic needle, simulation and validation, testing and services, are the key value creation driver for the Company.
About Lotus Eye Hospital & Institute Ltd
Lotus Eye Hospital & Institute Limited, a trust hospital, was originally incorporated as 'Kalaivani Health Centre Pvt.
Limited' on 14 March, 1997.
The name of the Company was changed to 'Lotus Eye Care Hospital Pvt.
Limited' on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013.
Founded in 1990 by renowned ophthalmic surgeon late Dr. S.K. Sundaramoorthy, the Company operates 9 Eye Care centers in Tamil Nadu and Kerala: 7 Centres in Tamil Nadu: Coimbatore (Peelamedu, RS puramand Saravanampatti), Salem , Tirupur Mettupalayam and Karur. 2 Centresin Kerala: Kochi and Mulanthuruthy.
Lotus Eye Care Hospital is the state of art eye care hospital group functioning in South India with specialization in super-specialty service related to eye care.
FAQs for the comparison of Centenial Surgical Suture Ltd and Lotus Eye Hospital & Institute Ltd
Which company has a larger market capitalization, Centenial Surgical Suture Ltd or Lotus Eye Hospital & Institute Ltd?
Market cap of Centenial Surgical Suture Ltd is 24 Cr while Market cap of Lotus Eye Hospital & Institute Ltd is 234 Cr
What are the key factors driving the stock performance of Centenial Surgical Suture Ltd and Lotus Eye Hospital & Institute Ltd?
The stock performance of Centenial Surgical Suture Ltd and Lotus Eye Hospital & Institute Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Centenial Surgical Suture Ltd and Lotus Eye Hospital & Institute Ltd?
As of October 25, 2026, the Centenial Surgical Suture Ltd stock price is INR ₹67.95. On the other hand, Lotus Eye Hospital & Institute Ltd stock price is INR ₹112.75.
How do dividend payouts of Centenial Surgical Suture Ltd and Lotus Eye Hospital & Institute Ltd compare?
To compare the dividend payouts of Centenial Surgical Suture Ltd and Lotus Eye Hospital & Institute Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.